Jay Shepard
Director/Board Member at ESPERION THERAPEUTICS, INC.
Net worth: 932 423 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gail McIntyre | M | 61 | 6 years | |
| Mark Pearson | M | 57 |
Cessation Therapeutics, LLC
 Cessation Therapeutics, LLC Pharmaceuticals: MajorHealth Technology Cessation Therapeutics, LLC is a clinical-stage pharmaceutical company that develops immunobiologics to prevent and protect against overdose. The company is based in San Jose, CA. The company's monoclonal antibodies are designed to target fentanyl and future synthetic opioids and other substances. The company has the potential to treat a range of substance use disorders and improve the lives of patients and families affected by the addiction crisis. Cessation was founded in 2018 by Mark Pearson and John D. Harkey, Jr., experienced, successful long-term biotech investors. The CEO is Mark E. Pearson.
Altamont Pharma Acquisition Corp.
 Altamont Pharma Acquisition Corp. Financial ConglomeratesFinance Altamont Pharma Acquisition Corp. is a blank check company. It engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on January 6, 2021 and is headquartered in Austin, TX. | - |
| Jacqueline Shea | M | 58 | 5 years | |
| David G. Genecov | M | - |
Cessation Therapeutics, LLC
Cessation Therapeutics, LLC Pharmaceuticals: MajorHealth Technology Cessation Therapeutics, LLC is a clinical-stage pharmaceutical company that develops immunobiologics to prevent and protect against overdose. The company is based in San Jose, CA. The company's monoclonal antibodies are designed to target fentanyl and future synthetic opioids and other substances. The company has the potential to treat a range of substance use disorders and improve the lives of patients and families affected by the addiction crisis. Cessation was founded in 2018 by Mark Pearson and John D. Harkey, Jr., experienced, successful long-term biotech investors. The CEO is Mark E. Pearson. | - |
| Thomas McCourt | M | 66 | 15 years | |
| Sheldon Koenig | M | 58 | 4 years | |
| Tracy M. Woody | F | 54 |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | 7 years |
| Ashwin Ram | M | - |
Catalys Pacific LLC
 Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands.
Pathalys Pharma, Inc.
 Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler. | - |
| Jandell T. Allen-Davis | M | - |
Craig Hospital
 Craig Hospital Hospital/Nursing ManagementHealth Services Craig Hospital is a center for specialty rehabilitation and research for people with spinal cord injury and traumatic brain injury. The firm provides a system of inpatient and outpatient medical care, rehabilitation, neurosurgical rehabilitative care and long-term follow up services. The company was founded in 1907 and is headquartered in Denver, CO. | 6 years |
| Neal Fowler | M | 62 |
Pathalys Pharma, Inc.
Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler.
Catalys Pacific LLC
Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands. | - |
| Julie McHugh | F | 59 | 10 years | |
| Simon Benito | M | 79 | 21 years | |
| Robert Finocchio | M | 72 |
Santa Clara University
| 24 years |
| Michael Hindery | M | - |
Santa Clara University
| 10 years |
| Thomas E. Balazy | M | - |
Craig Hospital
Craig Hospital Hospital/Nursing ManagementHealth Services Craig Hospital is a center for specialty rehabilitation and research for people with spinal cord injury and traumatic brain injury. The firm provides a system of inpatient and outpatient medical care, rehabilitation, neurosurgical rehabilitative care and long-term follow up services. The company was founded in 1907 and is headquartered in Denver, CO. | 37 years |
| David Weiner | M | 67 | 41 years | |
| Stephen Rocamboli | M | 52 | 2 years | |
| Marianne Andreach | F | - | - | |
| Catherine Moukheibir | F | 64 | 5 years | |
| Radha Basu | F | 73 |
Santa Clara University
| 14 years |
| Mahesh Krishnan | M | 53 |
Pathalys Pharma, Inc.
Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler. | - |
| Lisa Walters-Hoffert | F | 65 |
Altamont Pharma Acquisition Corp.
Altamont Pharma Acquisition Corp. Financial ConglomeratesFinance Altamont Pharma Acquisition Corp. is a blank check company. It engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on January 6, 2021 and is headquartered in Austin, TX. | - |
| Ann Miller | M | 66 | 5 years | |
| Jon Duane | M | 65 | 5 years | |
| Marla Kessler | F | 54 | 5 years | |
| BT Slingsby | M | 47 |
Pathalys Pharma, Inc.
Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler. | - |
| Benjamin Looker | M | 42 | 2 years | |
| Ronald Silver | M | 42 | 6 years | |
| John Minardo | M | 49 | 3 years | |
| Mike Nanfito | M | - | 12 years | |
| Roger Dansey | M | 68 | 3 years | |
| Andrew Dreyfus | M | 65 | 8 years | |
| Marcel Moulaison | M | - | 10 years | |
| Eric Warren | M | 76 | 3 years | |
| Benjamin Halladay | M | 38 | 4 years | |
| Lota Zoth | F | 64 | 6 years | |
| J. Carroll | M | 74 | 2 years | |
| Alan Fuhrman | M | 67 | 4 years | |
| Antonio M. Gotto | M | 88 | 10 years | |
| Fred Eshelman | M | 76 | 4 years | |
| Nicole Vitullo | F | 66 | 16 years | |
| Alexander Denner | M | 54 | 4 years | |
| Wendy Yarno | F | 69 | 7 years | |
| Byron Scordelis | M | 74 |
Santa Clara University
| - |
| Mark Currie | M | 69 | 4 years | |
| Michelle Barsanti | F | - |
Santa Clara University
| - |
| Julie Robson | F | - |
Santa Clara University
| - |
| Jerome Belotti | M | - |
Santa Clara University
| - |
| Rick Knauf | M | - |
Santa Clara University
| - |
| James Baldacci | M | - |
Santa Clara University
| - |
| Brian Zacharias | M | - |
Santa Clara University
| - |
| Charlene Raisch | F | - |
Santa Clara University
| - |
| Paula Garavaglia | F | - |
Santa Clara University
| - |
| Peter Drevno | M | - |
Santa Clara University
| - |
| Ann Vaudagna | F | - |
Santa Clara University
| - |
| Kenneth Rowell | M | - |
Santa Clara University
| - |
| Lisa Franzia | F | - |
Santa Clara University
| - |
| Janice Berthold | F | - |
Santa Clara University
| - |
| Carolyn Von Der Ahe | F | - |
Santa Clara University
| - |
| Joseph Pfahnl | M | - |
Santa Clara University
| - |
| Barbara Mellin | F | - |
Santa Clara University
| - |
| Mary Livak | F | - |
Santa Clara University
| - |
| Michael Campi | M | - |
Santa Clara University
| - |
| Carol Sisney | F | - |
Santa Clara University
| - |
| Mary Conlon-Almassy | F | - |
Santa Clara University
| - |
| John Bertolotti | M | - |
Santa Clara University
| - |
| Daniel Barsanti | M | - |
Santa Clara University
| - |
| Bill Cleary | M | - |
Santa Clara University
| - |
| Diana Brutoco | F | - |
Santa Clara University
| - |
| Peter J. M. Dalton | M | 80 |
Santa Clara University
| - |
| George Sollman | M | - |
Santa Clara University
| - |
| Timothy David Harris | M | 69 |
Santa Clara University
| - |
| Joseph Bronson | M | 75 |
Santa Clara University
| - |
| Regis P. McKenna | M | - |
Santa Clara University
| - |
| Wim Roelandts | M | 79 |
Santa Clara University
| 10 years |
| Peter Gotcher | M | 65 |
Santa Clara University
| - |
| Richard J. Justice | M | 74 |
Santa Clara University
| - |
| Steven Sordello | M | 54 |
Santa Clara University
| 11 years |
| Michael Crowley | M | - |
Santa Clara University
| - |
| Debra Engel | F | - |
Santa Clara University
| - |
| Deepa Arora | F | - |
Santa Clara University
| - |
| Mark Bonino | M | - |
Santa Clara University
| - |
| Margaret A. Taylor | F | - |
Santa Clara University
| - |
| Rebecca M. Guerra | F | - |
Santa Clara University
| - |
| Marc van den Berg | M | - |
Santa Clara University
| - |
| Cathleen Benko | F | 66 |
Santa Clara University
| - |
| Drew Starbird | M | - |
Santa Clara University
| - |
| Beth Calitri | F | - | 5 years | |
| Molly Joseph | F | 50 |
Santa Clara University
| - |
| Nicole Clawson | F | - |
Santa Clara University
| - |
| Diane Stroehmann | F | 46 | 5 years | |
| Michael Shetzline | M | 65 | 5 years | |
| Greg Martini | M | - | 7 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Srini Akkaraju Akkaraju | M | 56 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | 3 years |
| Mike Burdick | M | - |
NextWave Pharmaceuticals, Inc.
NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | 4 years |
| Gina Consylman | F | 52 | 7 years | |
| Tim Mayleben | M | 63 | 11 years | |
| J. Kim | M | 55 | 13 years | |
| Rekha Hemrajani | F | 54 | - | |
| Jason Rickard | M | 53 | 11 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
| Japan | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jay Shepard
- Personal Network